Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 69097-173

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 69097-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

914605d4 7326 445d B20e 6771eb67f7c4 01

Chemical structure diagram of Albuterol Sulfate, showing its molecular components including hydroxyl groups and a sulfate moiety.*

FDA Label Image

914605d4 7326 445d B20e 6771eb67f7c4 02

Chemical structure diagram of Ipratropium Bromide showing molecular bonds and atoms including bromide and water components.*

FDA Label Image

914605d4 7326 445d B20e 6771eb67f7c4 03

A line graph comparing lung function (liters) over 8 hours after dosing for Albuterol, Ipratropium, and Ipratropium Bromide and Albuterol Sulfate Inhalation Solution. The graph shows lung volume on the vertical axis and time in hours since dosing on the horizontal axis.*

FDA Label Image

914605d4 7326 445d B20e 6771eb67f7c4 04

Instructional diagram in four steps showing how to use a vial of solution for inhalation. Step 1: Tear one vial from the combipack and place remaining vials back into the pouch. Step 2: Twist off the cap of the vial to open it. Step 3: Squeeze the vial's content into the reservoir of the nebulizing chamber. Step 4: Discard the vial after use.*

FDA Label Image

914605d4 7326 445d B20e 6771eb67f7c4 05

Instructional diagram displaying the assembly of a respiratory inhalation solution device, showing one hand holding the inhaler and the other inserting a component, likely the mouthpiece or filter, into the top of the device. Labeled as Figure 2.*

FDA Label Image

914605d4 7326 445d B20e 6771eb67f7c4 06

Illustrations showing two methods of inhalation for Ipratropium Bromide and Albuterol Sulfate solution using a nebulizer. Figure 3 depicts inhalation through a mouthpiece, while Figure 4 shows inhalation using a face mask. Both images focus on the patient positioning and device handling during respiratory inhalation treatment.*

FDA Label Image

914605d4 7326 445d B20e 6771eb67f7c4 07

Label for Ipratropium Bromide and Albuterol Sulfate inhalation solution, USP, strength 0.5 mg and 3 mg per 3 mL. The label indicates it is a prediluted sterile unit-dose vial for inhalation only by Cipla USA Inc. The carton contains 30 vials of 5.3 mL each, with usage and storage instructions, and a barcode. The label emphasizes prescription-only use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.